AlainBouchardMD
Cardiology • Birmingham, ALAdult Congenital Heart Disease, Interventional Cardiology
Physician
Dr. Bouchard is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
2700 10th Ave
Birmingham, AL 35205Phone+1 205-939-7100Fax+1 205-939-7101- Is this information wrong?
Education & Training
University of California (San Francisco)Fellowship, Cardiovascular Disease, 1983 - 1986
University of Laval Faculty of MedicineClass of 1979
Certifications & Licensure
CA State Medical License 1983 - Present
AL State Medical License 1986 - 2024- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Cardiovascular Disease
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification Allscripts MyWay EHR, Allscripts, 2012
- Fellow (FACC) American College of Cardiology
Clinical Trials
- Renal Denervation Using the Vessix Renal Denervation System for the Treatment of Hypertension (REDUCE HTN:REINFORCE) Start of enrollment: 2015 Apr 01
Publications & Presentations
PubMed
- 17 citationsRandomized Trial of Targeted Transendocardial Mesenchymal Precursor Cell Therapy in Patients With Heart Failure.Emerson C Perin, Kenneth M Borow, Timothy D Henry, Farrell O Mendelsohn, Leslie W Miller, Elizabeth Swiggum, Eric D Adler, David H Chang, R David Fish, Alain Bouchard,...> ;Journal of the American College of Cardiology. 2023 Mar 7
- 40 citationsThe REDUCE HTN: REINFORCE: Randomized, Sham-Controlled Trial of Bipolar Radiofrequency Renal Denervation for the Treatment of HypertensionMichael A. Weber, SM Ajay J. Kirtane Md, Matthew R. Weir, Jai Radhakrishnan, Tony Das, Martin Berk, Farrell O. Mendelsohn, Alain Bouchard, German Larrain, Michael Haas...> ;JACC. Cardiovascular Interventions. 2020 Feb 24
- 20 citationsLong-Term Safety and Efficacy of Platinum Chromium Everolimus-Eluting Stents in Coronary Artery Disease: 5-Year Results From the PLATINUM Trial.Christopher R. Kelly, Paul S. Teirstein, Ian T. Meredith, Bruno Farah, Christophe Dubois, Robert L. Feldman, Joseph Dens, Nobuhisa Hagiwara, Abram C. Rabinowitz, Didie...> ;JACC. Cardiovascular Interventions. 2017 Dec 11
- Join now to see all
Press Mentions
St. Vincent’s Conducting Phase III Trial for New Anticoagulant TreatmentsDecember 21st, 2023
Professional Memberships
- Member
Hospital Affiliations
- Princeton Baptist Medical CenterBirmingham, Alabama
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
